跳至主要内容
临床试验/NL-OMON47511
NL-OMON47511已完成4 期

Strengthening memory immunity in the aged population by vaccinating pre-elderly - StimulAge study

RIVM0 个研究点目标入组 207 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
207

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, participants must meet
  • all of the following criteria:
  • * General good health
  • * 50-65 years of age
  • * Provision of written informed consent;
  • * Adherent to protocol and available during the study period.

排除标准

  • Any of the following criteria will exclude a participant from this study:, *
  • Antibiotic use within 14 days of enrollment;
  • * Present evidence of serious disease(s) demanding immunosuppressive medical
  • treatment, like corticosteroids, that might interfere with the results of the
  • study within the last 3 months;
  • * Known or suspected allergy to any of the vaccine components (by medical
  • * Occurrence of serious adverse event after other vaccination (by medical
  • * Known or suspected immune deficiency;
  • * History of any neurologic disorder, including epilepsy;* Known or suspected coagulation disorder;
  • * Previous administration of serum products (including immunoglobulins) within
  • 6 months before vaccination and blood sampling;
  • * Hormone use, such as post-menopausal hormone or contraceptive pills, within
  • the last 3 months;
  • * Serious surgery within the last 3 months;
  • * Previous vaccination with the MenC, MenC-TT, or MenACWY-TT vaccine. (for the
  • MenACWY-TT study group )
  • * Previous meningococcal episode (MenACWY-TT study group)
  • * Previous vaccination with VZV vaccine (for the VZV study group)
  • * Previous Varicella Zoster episode (VZV study group)
  • * Vaccination with DT, DT-IPV, TdaP or T within the past 5 years (for the
  • MenACWY-TT study group)
  • * Any vaccination within a month before enrollment;
  • * Pregnant at the start of the study;

研究者

发起方
RIVM

相似试验